The GLP is committed to full transparency. Download and review our 2019 Annual Report

Jury in third glyphosate-cancer trial orders Bayer to pay over $2 billion in damages—eighth-largest ever product-defect claim

| | May 14, 2019

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Bayer AG was ordered to pay more than $2 billion in damages to a California couple that claimed they got cancer as a result of using the company’s Roundup weedkiller for about 30 years.

Related article:  Black-white cancer mortality gap has narrowed significantly, 'but we still have a long way to go'

It’s the largest jury award in the U.S. so far this year and the eighth-largest ever in a product-defect claim, according to data compiled by Bloomberg. Bayer, which said it will appeal the verdict, has now lost three trials in a row over claims Roundup causes cancer.

Read full, original article: Bayer Ordered by Jury to Pay $2 Billion Damages in Roundup Trial

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend